"True.Cell.Type","Predicted.Main.Cell.Type","Predicted.Sub.Cell.Types","Possible.Mixed.Cell.Types","Marker.Number","Marker.List","Iterations","Model","Provider","Tissue","Species","Additional.Info","Conversation.History","Score","Scoring_Reasoning","Merged_Grouping_1","Merged_Grouping_2","Merged_Grouping_3"
"cd8-positive, alpha-beta t cell","Cytotoxic Lymphocytes","Natural Killer (NK) Cells, CD8+ Cytotoxic T Lymphocytes (CTLs), Gamma-Delta (γδ) T Cells","Natural Killer (NK) Cells, CD8+ Cytotoxic T Lymphocytes (CTLs), Gamma-Delta (γδ) T Cells",50,"KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2",1,"google/gemini-2.5-flash-preview","openrouter","large intestine","human",NA,"Final Annotation Agent: Okay, I will perform a comprehensive cell type annotation for the provided single-cell cluster from human large intestine tissue, following the requested step-by-step process. **Input Marker List (ranked by expression intensity, high to low):** KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2 --- **Step 1: List the Key Functional Markers** These markers are indicative of specific cellular functions, particularly immune responses, cytotoxicity, and cytokine signaling. * **Cytotoxicity/Granzyme/Perforin Pathway:** * **GZMH, GZMA, GZMB, GZMK, GZMM:** Granzymes are serine proteases released by cytotoxic T lymphocytes (CTLs) and Natural Killer (NK) cells to induce apoptosis in target cells. Their presence is a strong indicator of cytotoxic activity. * **PRF1 (Perforin 1):** A pore-forming protein essential for the delivery of granzymes into target cells, a hallmark of cytotoxic immune cells. * **NKG7:** A transmembrane protein found in the granules of NK cells and CTLs, involved in granule exocytosis and cytotoxicity. * **CTSW (Cathepsin W):** A cysteine protease expressed in NK cells and T cells, potentially involved in granule maturation or processing of cytotoxic molecules. * **Chemokines/Cytokines and Receptors:** * **XCL2, XCL1:** Lymphotactin (XCL1/2) are C-motif chemokines primarily produced by NK cells and CD8+ T cells, involved in attracting immune cells. * **CCL4, CCL4L2, CCL5:** Chemokine (C-C motif) ligand 4 (MIP-1β) and 5 (RANTES) are potent chemoattractants for various immune cells, including T cells, NK cells, and macrophages, often produced during inflammation and immune responses. * **IFNG (Interferon Gamma):** A crucial cytokine produced by NK cells and T cells, particularly Th1 and CD8+ T cells, known for its potent antiviral, anti-tumor, and immunomodulatory effects. * **IL21R (Interleukin 21 Receptor):** Receptor for IL-21, a cytokine important for the differentiation and function of T cells, B cells, and NK cells. * **Immune Checkpoints/Co-inhibitory/Co-stimulatory Molecules:** * **TIGIT (T cell immunoreceptor with Ig and ITIM domains):** An inhibitory receptor expressed on T cells and NK cells, involved in immune evasion and exhaustion. * **LAG3 (Lymphocyte-activation gene 3):** An inhibitory receptor expressed on activated T cells and NK cells, contributing to immune exhaustion. * **TNFRSF9 (CD137/4-1BB):** A co-stimulatory receptor expressed on activated T cells and NK cells, promoting cell survival and proliferation. * **Other Immune-related Functions:** * **CD160:** A receptor expressed on NK cells, CD8+ T cells, and γδ T cells, involved in both activating and inhibitory signaling. * **CRTAM (Class I-restricted T cell-associated molecule):** A cell surface receptor expressed on NK cells and CD8+ T cells, involved in cell-cell adhesion and activation. * **PTPN22:** A protein tyrosine phosphatase involved in regulating T cell activation. * **SH2D1A:** Involved in NK cell and T cell signaling, mutations cause X-linked lymphoproliferative disease. --- **Step 2: List the Key Cell Type Markers** These markers are highly specific to particular immune cell lineages, especially those with cytotoxic capabilities. * **Natural Killer (NK) Cell Markers:** * **KLRC2 (NKG2C), KLRK1 (NKG2D), KLRC4 (NKG2E), KLRD1 (CD94):** These are members of the C-type lectin-like receptor family, characteristic of NK cells. NKG2C/D/E and CD94 form complexes that recognize MHC class I molecules or MHC class I-like molecules, playing crucial roles in NK cell activation and inhibition. Their high expression, especially KLRC2 and KLRK1, is a strong indicator of NK cells. * **CD160:** While also on T cells, it's a prominent NK cell marker. * **NKG7:** As mentioned, found in NK cells and CTLs. * **XCL1, XCL2:** Often produced by NK cells. * **GZMH, GZMB, PRF1:** While also in CTLs, these are core NK cell cytotoxic machinery. * **Cytotoxic T Lymphocyte (CTL) Markers (CD8+ T cells):** * **CD8B, CD8A:** Coreceptors that define CD8+ T cells, which are primarily cytotoxic. Their presence is definitive for CD8+ T cells. * **GZMH, GZMA, GZMB, GZMK, GZMM, PRF1, NKG7:** These cytotoxic effector molecules are highly expressed in activated CD8+ T cells. * **TRGC2, TRGC1:** These indicate the presence of T cell receptor gamma chain, suggesting gamma-delta (γδ) T cells. γδ T cells can also exhibit cytotoxic functions and share some markers with NK cells and αβ T cells. * **CD7:** A pan-T cell marker, also found on NK cells. * **TIGIT, LAG3, TNFRSF9:** These are commonly expressed on activated and/or exhausted T cells, including CD8+ T cells. * **IFNG:** A key cytokine produced by activated CD8+ T cells. * **General Lymphocyte/Immune Cell Markers:** * **CD7:** Expressed on T cells and NK cells. * **GPR18:** A G protein-coupled receptor, expressed on various immune cells, including lymphocytes. * **ABI3:** Involved in actin dynamics and immune cell signaling. * **ZEB2:** A transcription factor involved in immune cell development and function, including NK cells and T cells. * **IKZF2 (Helios):** A transcription factor expressed in regulatory T cells and activated conventional T cells, including CD8+ T cells. --- **Step 3: Cross-reference Known Databases** A quick cross-reference with common scRNA-seq atlases (e.g., Human Cell Atlas, Tabula Sapiens, PanglaoDB, Azimuth/Seurat reference datasets for immune cells) and literature confirms the strong association of these markers: * **NK Cell Signature:** The combination of `KLRC2, KLRK1, KLRC4, KLRD1, CD160, XCL1, XCL2, NKG7, GZMH, GZMB, PRF1` is a classic and robust signature for NK cells. * **CD8+ T Cell Signature:** The presence of `CD8A, CD8B, GZMA, GZMB, GZMK, PRF1, NKG7, IFNG, TIGIT, LAG3, TNFRSF9` is highly characteristic of cytotoxic CD8+ T cells. * **Gamma-Delta T Cell Signature:** `TRGC1, TRGC2` specifically point to γδ T cells, which can also be cytotoxic and share many effector molecules with NK and αβ CTLs. * **Overlap:** Many cytotoxic effector molecules (granzymes, perforin, NKG7, chemokines) are shared between NK cells and cytotoxic T cells (both αβ CD8+ and γδ T cells), reflecting their shared function. The key to distinguishing them lies in the presence of lineage-specific receptors (CD8A/B for αβ CTLs, TRGC1/2 for γδ T cells, and the KLR family for NK cells). The high expression of multiple KLR family members (KLRC2, KLRK1, KLRC4, KLRD1) alongside CD8A/B and TRGC1/2 suggests a mixed population or a cell type with features of both NK and T cells, or perhaps a highly activated state where NK-like receptors are upregulated on T cells. However, the *ranking* is crucial. KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1 are at the very top, preceding CD8B and CD8A. This suggests a strong NK cell component or NK-like features. --- **Step 4: Determine the Most Probable General Cell Type** Based on the overwhelming presence and high expression of cytotoxic effector molecules (granzymes, perforin, NKG7), chemokines (XCL1/2, CCL4/5), and specific lineage markers (KLR family, CD8A/B, TRGC1/2), the most probable general cell type is **Cytotoxic Lymphocytes**. This category encompasses Natural Killer (NK) cells, CD8+ Cytotoxic T Lymphocytes (CTLs), and Gamma-Delta (γδ) T cells, all of which are highly represented by the marker list. --- **Step 5: Identify the Top 3 Most Probable Sub Cell Types** Given the specific markers and their ranking, we can refine the annotation: 1. **Natural Killer (NK) Cells:** * **Reasoning:** The highest-ranked specific markers are `KLRC2, KLRK1, KLRC4, KLRD1`, which are definitive NK cell receptors. `XCL2, XCL1` are also highly expressed and commonly associated with NK cells. The presence of `CD160, NKG7, GZMH, GZMB, PRF1` further supports their cytotoxic function. The prominence of NK-specific markers at the very top of the list strongly suggests a significant NK cell population or a cell type with strong NK-like characteristics. * **Specific Markers:** KLRC2, KLRK1, KLRC4, KLRD1, XCL2, XCL1, CD160, NKG7. 2. **CD8+ Cytotoxic T Lymphocytes (CTLs):** * **Reasoning:** `CD8B` and `CD8A` are present and relatively high in the list, confirming the presence of CD8+ T cells. These cells are well-known for their cytotoxic function, supported by the expression of `GZMA, GZMB, GZMK, GZMM, PRF1, NKG7, IFNG`. The immune checkpoint markers `TIGIT, LAG3, TNFRSF9` are also characteristic of activated or exhausted CD8+ T cells. * **Specific Markers:** CD8B, CD8A, GZMA, GZMB, GZMK, PRF1, IFNG, TIGIT, LAG3, TNFRSF9. 3. **Gamma-Delta (γδ) T Cells:** * **Reasoning:** The presence of `TRGC2` and `TRGC1` (T cell receptor gamma chain constant regions) is a direct indicator of γδ T cells. These cells are a distinct T cell lineage, often found in mucosal tissues like the large intestine, and can exhibit potent cytotoxic functions, sharing many effector molecules (granzymes, perforin, chemokines) with NK cells and αβ CTLs. Their position in the list suggests they are present, though perhaps less dominant than the NK or αβ CD8+ populations based on the very top markers. * **Specific Markers:** TRGC2, TRGC1. **Most Likely Subtype:** Given the very high expression and top ranking of NK cell-specific markers (`KLRC2, KLRK1, KLRC4, KLRD1, XCL2, XCL1`), followed closely by general cytotoxic markers and then CD8+ T cell markers, the most likely subtype is **Natural Killer (NK) Cells**, potentially with a strong cytotoxic phenotype, or a cluster that is enriched for NK cells but also contains some highly activated CD8+ T cells and/or γδ T cells that share many cytotoxic features. The initial markers are overwhelmingly NK-centric. However, the co-expression of CD8A/B and TRGC1/2 ... [truncated]",92,"The annotation results provided demonstrate a thorough and scientifically accurate analysis of the single-cell cluster from human large intestine tissue. Here’s a detailed evaluation:

**Strengths:**
1. **Correctness of Annotations:** The annotations are highly accurate, aligning well with established knowledge of immune cell markers. The identification of **Natural Killer (NK) cells**, **CD8+ Cytotoxic T Lymphocytes (CTLs)**, and **Gamma-Delta (γδ) T cells** is supported by robust marker evidence. For example:
   - **NK cells:** The high expression of `KLRC2`, `KLRK1`, `KLRC4`, `KLRD1`, and `XCL1/2` is definitive for NK cells, and the inclusion of cytotoxic markers like `GZMH`, `GZMB`, and `PRF1` reinforces this.
   - **CD8+ CTLs:** The presence of `CD8A/B`, `GZMA/GZMB`, and immune checkpoint markers like `TIGIT` and `LAG3` is characteristic of activated/exhausted CD8+ T cells.
   - **γδ T cells:** The inclusion of `TRGC1/2` is specific to this subset, which is often overlooked but correctly identified here.

2. **Balanced Marker Consideration:** The analysis does not overemphasize a single marker but integrates multiple lines of evidence. For instance, it combines cytotoxic markers (`GZMs`, `PRF1`), lineage-specific receptors (`KLRC2`, `CD8A/B`), and functional markers (`IFNG`, `CCL4/5`) to build a comprehensive picture.

3. **General Picture Captured:** The annotation successfully distinguishes between overlapping populations (e.g., NK cells vs. CD8+ T cells) by leveraging marker ranking. The prioritization of `KLRC2` and `KLRK1` (NK markers) over `CD8A/B` suggests a dominant NK component, which is well-justified.

4. **Rank Consideration:** The analysis explicitly notes the importance of marker ranking (e.g., NK markers appearing before CD8+ T cell markers), which is critical for resolving mixed populations. This demonstrates attention to detail.

**Weaknesses:**
1. **Potential Oversight of Mixed Populations:** While the annotation acknowledges the possibility of mixed NK/CD8+/γδ T cell populations, it could more explicitly discuss whether this cluster represents a single hybrid population or a mixture of distinct subpopulations. For example, the high expression of both NK and T cell markers might suggest ""NK-like"" T cells (e.g., innate-like CD8+ T cells), which are not explicitly mentioned.

2. **Minor Marker Ambiguity:** Some markers (e.g., `CD160`, `NKG7`) are shared across NK and T cells, and while their roles are explained, the analysis could further clarify how their presence in this context supports the dominant NK annotation. For instance, `NKG7` is highly expressed in both NK and CD8+ T cells, so its weight in the decision could be elaborated.

3. **Limited Discussion of Tissue Context:** The human large intestine is a site with unique immune subsets (e.g., intraepithelial lymphocytes, mucosal-associated invariant T cells). While the annotation is correct, it might benefit from contextualizing the findings within the tissue’s immune landscape (e.g., noting the prevalence of γδ T cells in mucosal tissues).

**Overall:** The annotation is scientifically rigorous, with only minor room for refinement in addressing mixed populations and tissue-specific context. The balance of markers and attention to ranking are exemplary.","Lymphocytes","NK-like T cells","Cytotoxic CD8+ T cells"
"intestinal crypt stem cell","Intestinal Epithelial Cell","Intestinal Stem Cells (ISCs), Early Progenitor Cells (Transit-Amplifying Cells), Secretory Progenitor Cells","",50,"AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491.1, AC022968.1",1,"google/gemini-2.5-flash-preview","openrouter","large intestine","human",NA,"Final Annotation Agent: This is an excellent challenge. Let's break down this marker list to identify the cell type from human large intestine tissue. **Initial Scan and Strategy:** My immediate observation is the presence of several pseudogenes (indicated by 'P' in their names, e.g., RPL7P54, HMGN2P6, PPIAP40, etc.) and uncharacterized loci (e.g., AL031284.1, AC012085.1, AC010132.3). These are generally less informative for direct cell type identification as they often represent non-coding RNAs or genomic regions rather than functional protein-coding genes directly indicative of cell state. My strategy will be to prioritize the known protein-coding genes and then use the uncharacterized loci as supporting evidence if they are consistently co-expressed with known markers in specific cell types in databases. --- **Step-by-Step Analysis:** **1. List the Key Functional Markers:** * **LGR5 (Leucine-rich repeat-containing G protein-coupled receptor 5):** This is a canonical marker for adult stem cells in various tissues, most notably in the intestinal epithelium. LGR5+ cells are multipotent stem cells responsible for maintaining the intestinal crypts and regenerating the epithelium. Its high expression is a strong indicator of stemness. * **ASCL2 (Achaete-scute homolog 2):** A basic helix-loop-helix (bHLH) transcription factor. ASCL2 is a critical regulator of intestinal stem cell maintenance and proliferation. It is highly expressed in LGR5+ intestinal stem cells and is essential for their self-renewal and differentiation into various epithelial lineages. * **TDGF1 (Teratocarcinoma-derived growth factor 1, also known as Cripto-1):** A member of the epidermal growth factor-CFC (EGF-CFC) family. TDGF1 plays a crucial role in embryonic development, stem cell maintenance, and cancer. In the intestine, it is involved in Wnt signaling, which is vital for intestinal stem cell proliferation and crypt homeostasis. Its expression is often associated with stem/progenitor cell populations. * **IGFBPL1 (Insulin-like growth factor binding protein-like 1):** While not as specific as LGR5 or ASCL2, IGFBPL1 has been implicated in cell proliferation and differentiation, and its expression can be associated with actively dividing cells, including stem/progenitor populations. **Summary of Functional Markers:** The presence of LGR5, ASCL2, and TDGF1 together is a very strong signature for intestinal stem cells, indicating active proliferation and self-renewal pathways. **2. List the Key Cell Type Markers:** Given the tissue is human large intestine, I will focus on markers relevant to the intestinal epithelium. * **LGR5:** As discussed above, this is the quintessential marker for intestinal stem cells located at the base of the crypts. * **ASCL2:** Reinforces the identification of intestinal stem cells. * **TDGF1:** Further supports the stem/progenitor cell identity within the intestinal epithelium. * **SLC39A2 (Solute Carrier Family 39 Member 2, also known as ZIP2):** This gene encodes a zinc transporter. While not a primary cell type marker, zinc transporters are involved in various cellular processes, including proliferation and differentiation. Its expression can be found in various epithelial cells, including those in the intestine, and its specific role in stem cells might be related to their high metabolic activity or specific signaling pathways. **Summary of Cell Type Markers:** The combination of LGR5, ASCL2, and TDGF1 overwhelmingly points towards intestinal stem cells. SLC39A2 is a more general epithelial marker but does not contradict the stem cell identity. **3. Cross-reference Known Databases:** I would virtually cross-reference these markers with established scRNA-seq datasets and atlases of the human large intestine (e.g., Human Cell Atlas, Tabula Sapiens, specific gut scRNA-seq studies). * **LGR5 and ASCL2:** These are consistently co-expressed and define the canonical intestinal stem cell population in all major human and mouse intestinal scRNA-seq atlases. They are typically found at the very bottom of the crypts. * **TDGF1:** Often co-expressed with LGR5 and ASCL2 in intestinal stem cells, particularly in contexts of active Wnt signaling and proliferation. Some studies also show its expression in early progenitor cells. * **IGFBPL1:** While less specific, it has been reported in various epithelial cell types, including some stem/progenitor populations in the gut. * **SLC39A2:** Found in various epithelial cells, including intestinal stem cells and their immediate progeny, reflecting its role in general cellular metabolism and ion transport. The pseudogenes and uncharacterized loci (e.g., AL031284.1, AC012085.1, AC010132.3, etc.) are less likely to be direct cell type identifiers. However, their high expression suggests they might be actively transcribed in this specific cell state. In a real-world scenario, I would check if these specific pseudogenes or lncRNAs have been previously associated with intestinal stem cells in other datasets, as some non-coding RNAs can play regulatory roles in stem cell biology. Without specific literature linking them, I will treat them as less informative for primary annotation. **4. Determine the Most Probable General Cell Type:** Based on the overwhelming evidence from LGR5, ASCL2, and TDGF1, the most probable general cell type is **Intestinal Epithelial Cell**. More specifically, it is a highly specialized subset within the epithelium. **5. Identify the Top 3 Most Probable Sub Cell Types:** 1. **Intestinal Stem Cells (ISCs):** This is by far the most probable subtype. The co-expression of LGR5, ASCL2, and TDGF1 is the defining molecular signature of actively cycling, multipotent intestinal stem cells located at the crypt base. These cells are responsible for the continuous renewal of the intestinal epithelium. 2. **Early Progenitor Cells (Transit-Amplifying Cells):** While LGR5 and ASCL2 are highest in ISCs, some early progenitor cells (also known as transit-amplifying or TA cells) that have just exited the stem cell state might still express detectable levels of these markers, albeit typically at lower levels than true ISCs. TDGF1 can also be present in these cells. However, the high ranking of LGR5 and ASCL2 suggests a more 'stem-like' identity. 3. **Secretory Progenitor Cells:** In some contexts, particularly during differentiation towards secretory lineages (e.g., Paneth cells, goblet cells, enteroendocrine cells), there can be transient expression of stem cell markers or markers associated with early commitment. However, without specific secretory lineage markers (e.g., MUC2 for goblet, CHGA for enteroendocrine, LYZ for Paneth), this is less likely than a general stem/early progenitor state. **Most Likely Subtype:** The most likely subtype is **Intestinal Stem Cells (ISCs)**. The presence of LGR5 and ASCL2 as top markers is the gold standard for identifying these cells in the intestinal epithelium. TDGF1 further supports this, as it is involved in Wnt signaling, which is crucial for ISC maintenance. **6. Provide a Concise Summary of Your Analysis:** The provided marker list for a cluster of cells from human large intestine tissue strongly indicates **Intestinal Stem Cells (ISCs)**. The high expression of canonical stem cell markers such as **LGR5** and **ASCL2**, coupled with **TDGF1** (involved in Wnt signaling and stem cell maintenance), provides compelling evidence for this annotation. These cells are responsible for the continuous renewal of the intestinal epithelium. The other identified protein-coding gene, SLC39A2, is consistent with an epithelial cell type. The numerous pseudogenes and uncharacterized loci, while highly expressed, are less informative for direct cell type identification but may represent actively transcribed non-coding elements within this specific stem cell population. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: { 'main_cell_type': 'Intestinal Epithelial Cell', 'sub_cell_types': [ 'Intestinal Stem Cells (ISCs)', 'Early Progenitor Cells (Transit-Amplifying Cells)', 'Secretory Progenitor Cells' ], 'possible_mixed_cell_types': [], 'num_markers': 50 }",95,"The annotation results provided are highly accurate and well-reasoned, demonstrating a deep understanding of single-cell marker analysis and intestinal stem cell biology. Here’s a detailed evaluation:

### Strengths:
1. **Correctness of Annotations**: The annotation correctly identifies the cluster as **Intestinal Stem Cells (ISCs)** based on the presence of canonical markers like **LGR5**, **ASCL2**, and **TDGF1**. These markers are scientifically validated and widely accepted in the literature as definitive for ISCs in the human large intestine. The inclusion of **SLC39A2** as a supporting marker for epithelial cells is also appropriate, as it aligns with the metabolic activity of stem cells.

2. **Balanced Consideration of Markers**: The analysis does not overemphasize a single marker but instead integrates multiple markers to build a robust case for ISCs. For example:
   - **LGR5** is highlighted as the ""gold standard"" for ISCs.
   - **ASCL2** is noted as a critical transcription factor for stem cell maintenance.
   - **TDGF1** is linked to Wnt signaling, reinforcing the stem cell identity.
   - **IGFBPL1** and **SLC39A2** are discussed as supplementary markers, adding depth to the analysis.

3. **Comprehensive View of Cell Types**: The annotation provides a nuanced understanding of the cluster by considering sub-cell types:
   - **Intestinal Stem Cells (ISCs)** are the primary focus, which is justified by the marker profile.
   - **Early Progenitor Cells** and **Secretory Progenitor Cells** are mentioned as less likely but plausible alternatives, demonstrating a thorough exploration of possibilities.

4. **Attention to Marker Rank**: The analysis acknowledges the importance of marker rank (e.g., **LGR5** and **ASCL2** appearing early in the list) and uses this to prioritize the most significant markers for annotation.

5. **Handling of Pseudogenes and Uncharacterized Loci**: The annotation correctly notes that pseudogenes (e.g., **RPL7P54**, **HMGN2P6**) and uncharacterized loci (e.g., **AL031284.1**) are less informative for direct cell typing but may have regulatory roles. This reflects a realistic and cautious approach to interpreting such data.

### Weaknesses:
1. **Lack of Experimental Validation Context**: While the annotation is theoretically sound, it does not address whether the marker list is derived from a specific dataset (e.g., scRNA-seq, proteomics) or experimental conditions. This context could further strengthen the confidence in the annotation.

2. **Limited Discussion of Potential Contaminants**: The analysis does not explicitly consider whether other cell types (e.g., immune cells or stromal cells) might contribute to the marker list, though the strong ISC signal likely minimizes this concern.

3. **Over-reliance on Canonical Markers**: While the use of **LGR5**, **ASCL2**, and **TDGF1** is justified, the analysis could explore whether any of the less-characterized markers (e.g., **IGFBPL1** or **SLC39A2**) have unique roles in ISCs that are not yet widely reported.

### Overall:
The annotation is scientifically rigorous, well-balanced, and captures the general picture of the cell population effectively. Minor improvements could be made by addressing experimental context and potential contaminants, but the analysis is already highly reliable.","Epithelial cells","Intestinal stem cells","Intestinal stem cells (ISCs)"
"intestinal enteroendocrine cell","Enteroendocrine Cell","L-cells, Enterochromaffin (EC) cells, S-cells","Enterochromaffin (EC) cells, S-cells",50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",1,"google/gemini-2.5-flash-preview","openrouter","large intestine","human",NA,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** * **GCG (Glucagon):** Encodes glucagon, a peptide hormone primarily known for its role in glucose homeostasis, increasing blood glucose levels. In the intestine, GCG-expressing cells are often enteroendocrine L-cells, which also produce GLP-1 and GLP-2. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** Also known as PC1/3. A proprotein convertase involved in the proteolytic processing of prohormones and proneuropeptides into their active forms. Essential for the maturation of many peptide hormones, including glucagon, insulin, and somatostatin. Its presence indicates active peptide hormone synthesis and processing. * **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone (CRH) family. Expressed in specific neuronal populations and endocrine cells, including enteroendocrine cells, where it can regulate gut motility and secretion. * **PYY (Peptide YY):** A peptide hormone secreted by L-cells in the gut in response to food intake. It plays a crucial role in regulating appetite, promoting satiety, and slowing gastric emptying. * **INSL5 (Insulin-like 5):** A relaxin family peptide hormone primarily expressed in enteroendocrine L-cells of the colon. Its exact physiological role is still being elucidated, but it's implicated in gut motility and potentially glucose metabolism. * **CHGA (Chromogranin A):** A general marker for neuroendocrine cells. It's an acidic glycoprotein stored and co-secreted with peptide hormones and neuropeptides from neuroendocrine cells. Its presence strongly suggests an endocrine or neuroendocrine cell type. * **SCG2 (Secretogranin II):** Another granin family protein, similar to CHGA, found in secretory granules of neuroendocrine cells. Involved in the packaging and release of peptide hormones. * **FEV (Fifth Ewing Variant):** A transcription factor involved in the development and differentiation of neuroendocrine cells, particularly those producing serotonin (5-HT). * **CPLX2 (Complexin 2):** A neuronal protein involved in synaptic vesicle exocytosis. Its presence in an endocrine context suggests a highly regulated secretory mechanism, characteristic of neuroendocrine cells. * **NKX2-2 (NK2 Homeobox 2):** A homeodomain transcription factor critical for the development and differentiation of specific neuronal and endocrine cell types, including pancreatic alpha cells and enteroendocrine cells. * **SCGN (Secretagogin):** A calcium-binding protein found in neuroendocrine cells, involved in regulated exocytosis. * **SLC18A1 (Solute Carrier Family 18 Member A1):** Also known as VMAT1 (Vesicular Monoamine Transporter 1). Involved in the uptake of monoamines (like serotonin) into secretory vesicles. Its presence suggests the potential for monoamine synthesis and secretion. * **SCG3 (Secretogranin III):** Another granin family protein, similar to CHGA and SCG2, found in neuroendocrine secretory granules. * **SCG5 (Secretogranin V):** Also known as 7B2. A neuroendocrine protein that acts as a chaperone for prohormone convertase PCSK1, facilitating its proper folding and activity. Its co-expression with PCSK1 is highly indicative of active prohormone processing. * **TPH1 (Tryptophan Hydroxylase 1):** The rate-limiting enzyme in serotonin (5-HT) biosynthesis. Its presence strongly indicates serotonin-producing cells. * **INSM1 (Insulinoma-associated 1):** A zinc finger transcription factor crucial for the differentiation and maintenance of neuroendocrine cells, including enteroendocrine cells. It's a pan-neuroendocrine marker. * **SNAP25 (Synaptosomal-Associated Protein, 25kDa):** A SNARE protein involved in membrane fusion and exocytosis, particularly in neurons and neuroendocrine cells, facilitating the release of neurotransmitters and hormones. * **CHGB (Chromogranin B):** Another granin family protein, similar to CHGA, found in secretory granules of neuroendocrine cells. * **RFX6 (Regulatory Factor X6):** A transcription factor essential for the development and differentiation of various endocrine cell types, including pancreatic islet cells and enteroendocrine cells. * **ABCC8 (ATP Binding Cassette Subfamily C Member 8):** Encodes SUR1, a subunit of the ATP-sensitive potassium channel (KATP channel). KATP channels are critical for glucose-stimulated hormone secretion in pancreatic beta cells and are also found in some enteroendocrine cells, regulating their excitability and hormone release. * **SCT (Secretin):** A peptide hormone secreted by S-cells in the duodenum in response to acidic chyme. It stimulates bicarbonate secretion from the pancreas and bile ducts. * **ARX (Aristaless Related Homeobox):** A transcription factor involved in the development of various cell types, including pancreatic alpha cells and some enteroendocrine cells. * **INA (Internexin Alpha):** An intermediate filament protein found in neurons and neuroendocrine cells. * **SLC5A8 (Solute Carrier Family 5 Member 8):** A sodium-coupled monocarboxylate transporter. Its expression in enteroendocrine cells, particularly L-cells, has been noted, potentially involved in nutrient sensing. **Step 2. List the Key Cell Type Markers:** Based on the functional markers, the overwhelming evidence points towards an enteroendocrine cell lineage. Therefore, the 'cell type markers' are largely overlapping with the 'functional markers' in this context, as the function *defines* the cell type. * **Pan-enteroendocrine/Neuroendocrine Markers:** CHGA, CHGB, SCG2, SCG3, SCG5, PCSK1, INSM1, SNAP25, CPLX2, SLC18A1, INA. These markers indicate a general neuroendocrine identity with active hormone synthesis and secretion machinery. * **L-cell specific/enriched markers:** GCG, PYY, INSL5. These are classic markers for L-cells, which are abundant in the colon and distal small intestine. * **K-cell/L-cell related markers:** GCG (proglucagon processing can lead to GIP in K-cells and GLP-1/2 in L-cells). * **S-cell specific marker:** SCT. Secretin-producing cells are primarily found in the duodenum. * **EC-cell related markers:** TPH1, SLC18A1. These indicate serotonin (5-HT) production, characteristic of enterochromaffin (EC) cells. * **Developmental/Transcription Factors:** FEV, NKX2-2, RFX6, ARX. These transcription factors are crucial for the specification and differentiation of various enteroendocrine subtypes. Their co-expression suggests a mature, differentiated enteroendocrine cell. * **Ion Channel/Transporter:** ABCC8, SLC5A8. These indicate specific physiological mechanisms related to excitability and nutrient sensing, common in enteroendocrine cells. **Step 3. Cross-reference Known Databases:** A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, specific gut scRNA-seq atlases) for these marker combinations consistently points to enteroendocrine cells, particularly L-cells and potentially other subtypes. * **GCG, PYY, INSL5, PCSK1, CHGA, SCG2, SCG3, SCG5, INSM1, RFX6, NKX2-2, ABCC8** are all highly characteristic of enteroendocrine cells, especially L-cells. * **TPH1, SLC18A1** are strong indicators of enterochromaffin (EC) cells. * **SCT** is a definitive marker for S-cells. * The co-expression of these diverse enteroendocrine markers suggests a cluster that might contain multiple enteroendocrine subtypes or a continuum of enteroendocrine cell states. However, the prominence of L-cell markers (GCG, PYY, INSL5) is striking. **Step 4. Determine the Most Probable General Cell Type:** Based on the overwhelming presence of pan-neuroendocrine markers (CHGA, PCSK1, INSM1, SCG2, SCG3, SCG5, SNAP25, CPLX2) and specific hormone/neuropeptide genes (GCG, PYY, INSL5, UCN3, SCT), the most probable general cell type is **Enteroendocrine Cell**. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given the specific markers, we can infer the most likely subtypes: 1. **L-cells:** * **Strong evidence:** GCG, PYY, INSL5, UCN3, PCSK1, CHGA, SCG2, SCG3, SCG5, INSM1, RFX6, NKX2-2, ABCC8. The presence of GCG, PYY, and INSL5 is highly specific to L-cells, which are the most abundant enteroendocrine cell type in the large intestine. The other markers support their neuroendocrine identity and processing machinery. * **Reasoning:** L-cells are known to produce glucagon-like peptides (derived from GCG), PYY, and INSL5. The high expression of these specific hormones, along with the general neuroendocrine machinery, strongly points to L-cells. 2. **Enterochromaffin (EC) cells:** * **Strong evidence:** TPH1, SLC18A1, CHGA, PCSK1, INSM1, SNAP25. TPH1 is the rate-limiting enzyme for serotonin synthesis, and SLC18A1 (VMAT1) is involved in packaging serotonin into vesicles. These are defining features of EC cells. * **Reasoning:** While L-cell markers are dominant, the clear presence of TPH1 and SLC18A1 indicates a significant contribution from or presence of EC cells within this cluster. EC cells are the most numerous enteroendocrine cell type in the gut and are responsible for serotonin production. 3. **S-cells:** * **Strong evidence:** SCT, CHGA, PCSK1, INSM1. SCT is the defining marker for S-cells. * **Reasoning:** The presence of SCT indicates that S-cells are also represented in this cluster. While S-cells are primarily found in the duodenum, their presence in the large intestine, albeit in lower numbers, is possible or this cluster might represent a broader enteroendocrine population that includes cells from different intestinal segments if the dataset is integrated. **Most Likely Subtype:** Based on the sheer number and specificity of the markers, the **L-cell** subtype is the most likely and dominant population within this cluster. GCG, PYY, and INSL5 are highly specific and abundant markers for L-cells, especially in the large intestine. The other general neuroendocrine markers support this identification. The presence of TPH1/S... [truncated]",95,"The annotation results demonstrate a high level of scientific accuracy and thoroughness in identifying the cell type based on the provided marker list. The analysis correctly identifies the cluster as enteroendocrine cells, specifically highlighting L-cells as the dominant subtype due to the presence of highly specific markers like GCG, PYY, and INSL5. The consideration of other enteroendocrine subtypes (EC cells and S-cells) adds depth to the annotation, showing a balanced use of multiple markers rather than over-focusing on a single one. 

Strengths:
1. **Correctness of Annotations:** The annotations are scientifically accurate, with clear justification for each identified subtype based on marker expression. For example, the combination of GCG, PYY, and INSL5 is highly specific for L-cells, and the inclusion of TPH1 and SLC18A1 correctly suggests EC cell presence.
2. **Balanced Marker Consideration:** The analysis does not rely solely on one or two markers but integrates a wide range of markers to support the annotation. This includes general neuroendocrine markers (CHGA, PCSK1) and subtype-specific markers (GCG, PYY for L-cells; TPH1 for EC cells).
3. **Comprehensive View:** The annotation provides a comprehensive view of the cell populations, acknowledging the possibility of multiple subtypes within the cluster. This reflects a good understanding of the heterogeneity in enteroendocrine cells.

Weaknesses:
1. **Marker Rank Consideration:** While the analysis is thorough, it could more explicitly consider the rank of markers (e.g., GCG appearing first) to emphasize their relative importance. This would strengthen the prioritization of L-cells as the dominant subtype.
2. **Truncated History:** The annotation history is truncated, which limits the ability to fully evaluate the reasoning process. However, the provided portion is robust and informative.

Overall, the annotation captures the general picture of the cell populations effectively, with only minor areas for improvement.","Epithelial cells","Enteroendocrine cells","Enteroendocrine L-cells"
"plasma cell","Plasma Cell","IgA-secreting Plasma Cells, IgG-secreting Plasma Cells, IgM-secreting Plasma Cells","",50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,"google/gemini-2.5-flash-preview","openrouter","large intestine","human",NA,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided ranked marker list from a human large intestine tissue scRNA-seq dataset: **1. List the Key Functional Markers:** * **Immunoglobulin Genes (IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHM, IGKV3-20, IGHA2):** This is the most prominent group of markers. These genes encode various components of immunoglobulins (antibodies), including light chains (IGL, IGK), heavy chains (IGH), and joining chains (JCHAIN). The presence of multiple variable (V), diversity (D), and joining (J) segments, as well as constant regions (C) for different isotypes (IgG1, IgG3, IgA1, IgA2, IgM), is highly indicative of antibody production. * **JCHAIN:** Essential for the polymerization of IgA and IgM, forming dimeric IgA and pentameric IgM. * **IGHA1, IGHA2:** Encode the alpha heavy chain, characteristic of IgA antibodies. IgA is the predominant antibody isotype in mucosal tissues like the large intestine. * **IGHG1, IGHG3:** Encode gamma heavy chains, characteristic of IgG antibodies. * **IGHM:** Encodes the mu heavy chain, characteristic of IgM antibodies. * **IGLC2, IGLC3, IGLL5, IGLV6-57, IGLV3-1, IGLV2-11:** Encode lambda light chain components. * **IGKC, IGKV4-1, IGKV1-5, IGKV3-20:** Encode kappa light chain components. * **MZB1 (Marginal Zone B and B1 Cell Specific Protein 1):** A chaperone protein involved in immunoglobulin assembly and secretion, highly expressed in plasma cells. * **TNFRSF17 (B Cell Maturation Antigen - BCMA):** A receptor for BAFF and APRIL, crucial for plasma cell survival and differentiation. Its expression is characteristic of plasma cells. * **GPRC5D (G Protein-Coupled Receptor Class C Group 5 Member D):** While its exact function in plasma cells is still being elucidated, it has been identified as a surface marker on plasma cells, particularly in multiple myeloma. * **FCRL5 (Fc Receptor Like 5):** An inhibitory Fc receptor expressed on B cells and plasma cells, involved in regulating B cell activation and antibody production. * **DERL3 (Derlin 3):** Involved in ER-associated degradation (ERAD), a process critical for handling misfolded proteins, which is highly active in cells with extensive protein synthesis and secretion, like plasma cells. * **TXNDC5 (Thioredoxin Domain Containing 5):** A protein disulfide isomerase (PDI) family member, involved in protein folding in the ER. High expression supports the extensive protein synthesis and secretion in plasma cells. **2. List the Key Cell Type Markers:** * **IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MZB1, IGHG3, IGHM, IGKV3-20, IGHA2:** As detailed above, the overwhelming presence and high expression of immunoglobulin genes (heavy and light chains, various isotypes, and JCHAIN) along with MZB1 and TNFRSF17 are the hallmarks of **plasma cells**. These cells are terminally differentiated B lymphocytes specialized in secreting large quantities of antibodies. * **CCL3 (Chemokine (C-C motif) Ligand 3):** While not exclusively a plasma cell marker, CCL3 (MIP-1α) can be produced by various immune cells, including plasma cells, and plays a role in immune cell recruitment. Its presence here is consistent with an immune cell type. * **LILRB4 (Leukocyte Immunoglobulin Like Receptor B4):** An inhibitory receptor expressed on myeloid cells, but also found on some B cell subsets and plasma cells, where it can modulate immune responses. * **BMP6 (Bone Morphogenetic Protein 6):** While primarily known for its role in bone and cartilage development, BMPs can have diverse roles in immunity and inflammation. Its expression in plasma cells is less common but not entirely unprecedented, potentially related to local tissue interactions or inflammatory responses. * **CCR10 (C-C Chemokine Receptor Type 10):** A chemokine receptor involved in cell migration. While not a definitive plasma cell marker, its expression can be found on certain B cell subsets and plasma cells, particularly those migrating to mucosal sites. * **APOBEC3A (Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide-like 3A):** An enzyme involved in innate immunity against retroviruses and retrotransposons. Its expression can be induced in various immune cells, including B cells and plasma cells, during immune responses. **3. Cross-reference Known Databases:** A quick search in scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, Azimuth) for 'plasma cell markers' consistently lists: * **High expression of immunoglobulin genes (IGHG1, IGHA1, IGHM, IGLC, IGKC, JCHAIN)** * **MZB1** * **TNFRSF17 (BCMA)** * **CD38 (often co-expressed, though not explicitly in this list, its function is related to TNFRSF17)** * **XBP1 (transcription factor for plasma cell differentiation, not in list but implied by the phenotype)** * **PRDM1 (BLIMP1, transcription factor for plasma cell differentiation, not in list but implied by the phenotype)** The provided list strongly aligns with the canonical markers for plasma cells, particularly the dominance of immunoglobulin genes and key accessory proteins like MZB1 and TNFRSF17. The presence of IgA (IGHA1, IGHA2) is highly relevant for large intestine tissue, as IgA is the primary antibody isotype in mucosal immunity. **4. Determine the Most Probable General Cell Type:** Based on the overwhelming expression of immunoglobulin genes (heavy and light chains of various isotypes, including IgA, IgG, IgM), JCHAIN, MZB1, and TNFRSF17, the most probable general cell type is **Plasma Cell**. These cells are terminally differentiated B lymphocytes whose primary function is antibody secretion. **5. Identify the Top 3 Most Probable Sub Cell Types:** Given the tissue (large intestine) and the specific immunoglobulin isotypes expressed, we can infer more specific subtypes: 1. **IgA-secreting Plasma Cells (Mucosal Plasma Cells):** This is the **most likely** subtype. The high expression of **IGHA1** and **IGHA2** (IgA heavy chains) is a strong indicator. IgA is the dominant antibody in mucosal tissues like the large intestine, playing a critical role in gut immunity by neutralizing pathogens and toxins at the epithelial surface. The presence of JCHAIN further supports the formation of dimeric IgA, which is secreted across the epithelium. 2. **IgG-secreting Plasma Cells:** The presence of **IGHG1** and **IGHG3** indicates the presence of IgG-secreting plasma cells. While IgA is dominant in the mucosa, IgG plasma cells are also found in the lamina propria of the intestine, contributing to systemic immunity and local inflammatory responses. 3. **IgM-secreting Plasma Cells:** The expression of **IGHM** suggests the presence of IgM-secreting plasma cells. IgM is typically the first antibody produced in a primary immune response and can also be found in mucosal tissues, often as a pentamer. **Most Likely Subtype:** **IgA-secreting Plasma Cells (Mucosal Plasma Cells)**. The prominence of IGHA1 and IGHA2, coupled with the large intestine tissue origin, makes this the most fitting and specific annotation. **6. Provide a Concise Summary of Your Analysis:** The provided marker list from human large intestine tissue is unequivocally indicative of **Plasma Cells**. The cluster exhibits high and broad expression of immunoglobulin heavy chain (IGHG1, IGHG3, IGHA1, IGHA2, IGHM) and light chain (IGKC, IGLC2, IGLC3) genes, along with JCHAIN, which are all essential components for antibody production and secretion. Furthermore, the presence of MZB1 and TNFRSF17 (BCMA) strongly supports a plasma cell identity, as these are key regulators of plasma cell differentiation, survival, and immunoglobulin secretion. Given the large intestine tissue context and the prominent expression of IgA heavy chains (IGHA1, IGHA2), the most probable specific subtype is **IgA-secreting Plasma Cells**, which are crucial for mucosal immunity in the gut. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: { 'main_cell_type': 'Plasma Cell', 'sub_cell_types': [ 'IgA-secreting Plasma Cells', 'IgG-secreting Plasma Cells', 'IgM-secreting Plasma Cells' ], 'possible_mixed_cell_types': [], 'num_markers': 50 }",95,"The annotation results provided are comprehensive and scientifically accurate, demonstrating a deep understanding of plasma cell biology and the specific context of the human large intestine. Here’s a detailed evaluation:

1. **Correctness of the Annotations**:  
   - The primary annotation as **Plasma Cell** is unequivocally correct, given the overwhelming presence of immunoglobulin genes (e.g., IGHA1, IGHA2, IGHG1, IGHM, IGLC, IGKC) and plasma cell-specific markers like MZB1, TNFRSF17, and JCHAIN. These markers are well-documented in literature and databases (e.g., Human Cell Atlas) for plasma cells.  
   - The sub-annotations (IgA-, IgG-, and IgM-secreting plasma cells) are also accurate, with IgA being highlighted as the dominant subtype due to the mucosal context of the large intestine. This aligns with the known biology of mucosal immunity, where IgA is the predominant isotype.

2. **Balanced Consideration of Markers**:  
   - The analysis does not overemphasize a single marker but instead integrates multiple lines of evidence, including:  
     - Immunoglobulin isotypes (IgA, IgG, IgM).  
     - Light and heavy chain diversity (IGLV, IGKV, IGL, IGK, IGH).  
     - Plasma cell-specific chaperones and regulators (MZB1, TNFRSF17, DERL3, TXNDC5).  
   - Even less common markers like GPRC5D, FCRL5, and LILRB4 are acknowledged, demonstrating a thorough review of the data.

3. **General Picture of Cell Populations**:  
   - The annotation captures the terminally differentiated, antibody-secreting nature of plasma cells and their relevance to mucosal immunity. The inclusion of IgA-secreting cells as the most probable subtype reflects the tissue context (large intestine) and the functional role of IgA in gut immunity.  
   - Minor markers like CCL3, BMP6, and APOBEC3A are noted but correctly contextualized as secondary or supportive rather than definitive for the annotation.

4. **Potential Weaknesses**:  
   - The analysis could briefly address why certain canonical plasma cell markers (e.g., CD38, XBP1, PRDM1) are absent, though their absence does not invalidate the annotation.  
   - While BMP6 and APOBEC3A are mentioned, their roles in plasma cells are less well-defined, and their inclusion could be slightly speculative. However, this does not detract from the overall accuracy.

5. **Marker Rank Consideration**:  
   - The analysis implicitly respects the rank of markers by prioritizing the most abundant immunoglobulin genes (e.g., IGHA1, IGHA2) and key plasma cell markers (MZB1, TNFRSF17) early in the discussion.  

**Strengths**:  
- Scientifically rigorous and well-supported by marker evidence.  
- Context-aware (large intestine mucosa) with appropriate subtype prioritization (IgA).  
- Comprehensive marker integration without over-reliance on a single gene.  

**Weaknesses**:  
- Minor oversight in not addressing absent canonical markers (e.g., CD38).  
- Slight overinterpretation of less-characterized markers (e.g., BMP6).  

Overall, the annotation is highly accurate and reflects a nuanced understanding of the data.","B cells","IgA plasma cells","IgA-secreting plasma cells"
"transit amplifying cell of large intestine","Proliferating Cells","Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs) / Crypt Base Columnar (CBC) Cells (Proliferating Subset), Proliferating Enterocyte Progenitors / Early Differentiating Cells","",50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,"google/gemini-2.5-flash-preview","openrouter","large intestine","human",NA,"Final Annotation Agent: This is an excellent challenge. I will proceed with a comprehensive, step-by-step analysis to identify the cell type from the provided ranked marker list, assuming this is a human large intestine scRNA-seq dataset. **Step-by-Step Analysis:** **1. List the Key Functional Markers:** The provided list is overwhelmingly enriched with genes involved in cell cycle progression, DNA replication, and mitosis. * **Cell Cycle Regulation & Mitosis:** * **MKI67 (Marker of Proliferation Ki-67):** A classic and highly reliable marker for proliferating cells. Its presence is a strong indicator of active cell division. * **CCNB2 (Cyclin B2):** A G2/M cyclin, essential for entry into and progression through mitosis. * **CDK1 (Cyclin-Dependent Kinase 1):** A key regulator of the G2/M transition and mitosis. * **PLK1 (Polo-like Kinase 1):** Crucial for multiple mitotic events, including centrosome maturation, spindle assembly, and cytokinesis. * **AURKB (Aurora Kinase B):** A chromosomal passenger complex component, vital for chromosome segregation and cytokinesis. * **BIRC5 (Survivin):** An anti-apoptotic protein and a key component of the chromosomal passenger complex, involved in cell division and apoptosis regulation. * **CENPA (Centromere Protein A):** A histone H3 variant specific to centromeres, essential for kinetochore formation and chromosome segregation. * **TOP2A (DNA Topoisomerase II Alpha):** Involved in DNA replication and chromosome condensation/segregation during mitosis. * **FOXM1 (Forkhead Box M1):** A transcription factor critical for cell cycle progression, particularly in G2/M phase, and often upregulated in proliferating cells. * **CDC25C (Cell Division Cycle 25C):** A phosphatase that activates CDK1, promoting entry into mitosis. * **GTSE1 (G2 and S-phase Expressed 1):** Involved in cell cycle regulation, particularly in G2/M. * **NEK2 (NIMA Related Kinase 2):** Involved in centrosome separation and spindle formation. * **NCAPG (Non-SMC Condensin I Complex Subunit G):** A component of the condensin complex, essential for chromosome condensation. * **PIMREG (PIM Kinase Regulator):** Involved in cell cycle progression. * **CDT1 (Chromatin Licensing And DNA Replication Factor 1):** Essential for DNA replication initiation. * **CCNA2 (Cyclin A2):** Involved in both S-phase and M-phase progression. * **Kinesin Family Members (Mitotic Spindle Function):** * **KIF2C (Kinesin Family Member 2C):** Involved in spindle assembly and chromosome segregation. * **KIF15 (Kinesin Family Member 15):** Plays a role in spindle pole separation and maintenance. * **KIF18B (Kinesin Family Member 18B):** Involved in chromosome alignment and segregation. * **Spindle Assembly & Kinetochore Components:** * **DLGAP5 (DLG Associated Protein 5):** Involved in spindle organization. * **CKAP2L (Cytoskeleton Associated Protein 2 Like):** Involved in microtubule organization. * **SPC25 (SPC25 Kinetochore Complex Component):** A component of the NDC80 kinetochore complex, essential for chromosome attachment to microtubules. * **ASPM (Abnormal Spindle Microtubule Assembly):** Involved in spindle pole integrity and mitotic progression. * **CEP55 (Centrosomal Protein 55):** Involved in cytokinesis. * **CDCA5 (Cell Division Cycle Associated 5):** Involved in sister chromatid cohesion and chromosome segregation. * **NUF2 (NUF2 Kinetochore Complex Component):** Another component of the NDC80 kinetochore complex. * **SKA3 (Spindle And Kinetochore Associated Complex Subunit 3):** Part of the SKA complex, crucial for stable microtubule-kinetochore attachments. * **SPC24 (SPC24 Kinetochore Complex Component):** Another component of the NDC80 kinetochore complex. * **OIP5 (OPA Interacting Protein 5):** A component of the MIS12 kinetochore complex. * **SKA1 (Spindle And Kinetochore Associated Complex Subunit 1):** Part of the SKA complex. * **DNA Replication & Repair:** * **RRM2 (Ribonucleotide Reductase M2):** Essential for DNA synthesis by providing deoxyribonucleotides. * **POLQ (DNA Polymerase Theta):** Involved in DNA repair, particularly alternative end-joining. * **GINS2 (GINS Complex Subunit 2):** A component of the GINS complex, essential for DNA replication initiation and elongation. * **RAD51AP1 (RAD51 Associated Protein 1):** Involved in homologous recombination DNA repair. * **TK1 (Thymidine Kinase 1):** Involved in DNA synthesis. * **CDC45 (Cell Division Cycle 45):** Essential for DNA replication initiation. * **Other Cell Cycle Related:** * **UBE2C (Ubiquitin Conjugating Enzyme E2 C):** Involved in ubiquitin-mediated proteolysis, crucial for cell cycle progression, especially mitotic exit. * **PBK (PDZ Binding Kinase):** Involved in cell cycle regulation and mitosis. * **DEPDC1 (DEP Domain Containing 1):** Involved in cell proliferation. * **PCLAF (PCNA Associated Factor):** Involved in DNA replication and repair. * **MND1 (Meiotic Nuclear Division 1 Homolog):** While primarily meiotic, its presence can sometimes indicate highly proliferative states or specific germline-like features in somatic cells. * **ZNF695 (Zinc Finger Protein 695):** Less directly linked to cell cycle, but some zinc finger proteins are involved in transcriptional regulation of cell cycle genes. * **DTL (Denticleless E3 Ubiquitin Protein Ligase Homolog):** Involved in DNA damage response and cell cycle control. * **PKMYT1 (Protein Kinase, Myosin Light Chain Kinase Related):** Involved in cell cycle regulation. * **CDCA3 (Cell Division Cycle Associated 3):** Involved in cell cycle progression. * **TTK (TTK Protein Kinase):** A key component of the spindle assembly checkpoint. * **DIAPH3 (Diaphanous Related Formin 3):** Involved in actin cytoskeleton organization and cytokinesis. * **IQGAP3 (IQ Motif And GTPase Activating Protein 3):** Involved in cell proliferation and migration. * **TROAP (Trophinin Associated Protein):** Involved in cell proliferation. **Summary of Functional Markers:** The overwhelming majority of the listed genes are canonical markers of active cell division, encompassing DNA replication, chromosome condensation, spindle formation, and cytokinesis. This strongly points towards a highly proliferative cell population. **2. List the Key Cell Type Markers:** The provided list does not contain typical lineage-specific markers (e.g., epithelial markers like EPCAM, immune markers like CD3E, stromal markers like DCN, or neuronal markers). Instead, it is almost exclusively composed of proliferation-associated genes. This suggests that the cluster is defined by its proliferative state rather than a specific differentiated cell type. * **No specific large intestine cell type markers are present in the list.** This is a critical observation. If this were, for example, a cluster of mature enterocytes, we would expect genes like *FABP1*, *APOA1*, *ALPI*. If it were goblet cells, *MUC2*, *TFF3*. If Paneth cells, *DEFA5*, *LYZ*. If immune cells, *PTPRC* (CD45) and specific T/B/myeloid markers. The absence of such markers, coupled with the strong presence of proliferation markers, indicates that these cells are likely undifferentiated or progenitor cells undergoing rapid division. **3. Cross-reference Known Databases:** A quick search of these markers (e.g., MKI67, TOP2A, CCNB2, CDK1, AURKB) in scRNA-seq atlases (e.g., Human Cell Atlas, Tabula Sapiens, specific large intestine datasets on GEO or ArrayExpress) consistently shows their high expression in: * **Proliferating cells:** This is the most direct and consistent association. * **Stem/progenitor cell compartments:** In tissues with high turnover, such as the intestine, these markers are highly expressed in the crypt base, where stem cells and transit-amplifying (TA) cells reside. * **Cancer cells:** Malignant cells often exhibit uncontrolled proliferation and express these markers. However, in the context of a 'normal' human large intestine dataset, this is less likely to be the primary annotation unless specified as a tumor sample. Specifically for the large intestine, these markers are characteristic of the **crypt base columnar (CBC) stem cells** and their rapidly dividing **transit-amplifying (TA) cell** progeny. **4. Determine the Most Probable General Cell Type:** Based on the overwhelming evidence from the functional markers, the most probable general cell type is **Proliferating Cells**. This cluster represents a population actively undergoing cell division. **5. Identify the Top 3 Most Probable Sub Cell Types:** Given the tissue context (human large intestine) and the strong proliferative signature, the top three most probable sub cell types are: 1. **Transit-Amplifying (TA) Cells:** These are the most likely candidates. TA cells are highly proliferative progeny of intestinal stem cells, located in the crypts, and are responsible for generating the vast majority of differentiated epithelial cells in the intestine. Their primary characteristic is rapid division, which perfectly matches the gene expression profile. The high expression of a broad range of mitotic and cell cycle genes (MKI67, TOP2A, CCNB2, CDK1, PLK1, AURKB, etc.) is a hallmark of TA cells. 2. **Intestinal Stem Cells (ISCs) / Crypt Base Columnar (CBC) Cells (Proliferating Subset):** While ISCs (specifically Lgr5+ CBC cells) are the ultimate source of all intestinal epithelial cells and are proliferative, they typically divide at a slower rate than TA cells and might express some stemness markers (e.g., *LGR5*, *OLFM4*, *ASCL2*) that are not present in this list. However, a subset of highly active ISCs would certainly express these proliferation markers. Given the sheer number and intensity of proliferation markers, it's more indicative of the highly proliferative TA population, which includes the immediate progeny of ISCs. 3. **Proliferating Enterocyte Progenitors / Early Differentiating Cells:** As TA cells divide, they begin to commit to specific lineages (e.g., enterocytes, goblet cells). Early progenitors t... [truncated]",92,"The annotation results provided are highly detailed and demonstrate a thorough understanding of the markers associated with cell proliferation and mitosis. The analysis correctly identifies the majority of the genes as being involved in cell cycle regulation, DNA replication, and mitosis, which is accurate given the marker list. The absence of lineage-specific markers is appropriately noted, reinforcing the conclusion that the cluster represents a proliferating cell population rather than a differentiated cell type. 

Strengths:
1. **Correctness of Annotations**: The annotation correctly identifies the proliferative nature of the cluster, supported by a comprehensive list of cell cycle and mitosis-related genes (e.g., MKI67, CCNB2, CDK1, PLK1, AURKB). This is scientifically accurate and aligns with known biological functions of these markers.
2. **Balanced Consideration of Markers**: The analysis does not overly focus on a single marker but instead considers a wide array of genes, providing a holistic view of the proliferative state. For example, it includes markers for spindle assembly (KIF2C, KIF15), kinetochore function (CENPA, NUF2), and DNA replication (RRM2, CDC45), among others.
3. **Comprehensive View**: The annotation provides a comprehensive view by cross-referencing known databases and considering the tissue context (human large intestine). It correctly narrows down the probable cell types to transit-amplifying (TA) cells and proliferating stem cells, which is reasonable given the data.

Weaknesses:
1. **Lack of Lineage-Specific Markers**: The analysis could have explicitly addressed the possibility of rare or low-expression lineage-specific markers that might have been missed, although their absence is noted. This could further refine the annotation.
2. **Overemphasis on Proliferation**: While the proliferative signature is undeniable, the analysis could briefly discuss potential caveats, such as the possibility of technical artifacts (e.g., cell cycle phase effects) or rare cell states that might overlap with proliferation markers.
3. **Truncated Analysis**: The annotation is cut off at the end, leaving some uncertainty about the final conclusions, particularly regarding the third sub-cell type (proliferating enterocyte progenitors). This incomplete section slightly detracts from the overall quality.

Overall, the annotation is scientifically sound, well-reasoned, and captures the general picture of the data effectively. The minor weaknesses do not significantly detract from the overall correctness and utility of the results.","Proliferating cells","Intestinal TA cells","Transit-amplifying (TA) cells"
